Friday, January 29, 2016

Weekly Links January 29th, 2016




“MUST READ”
The Gene Hackers At thirty-four, Feng Zhang is the youngest member of the core faculty at the Broad Institute of Harvard and M.I.T. He is also among the most accomplished. In 1999, while still a high-school student, in Des Moines, Zhang found a stru…
The Gene Factory The twenty-mile drive from Hong Kong International Airport to the center of Shenzhen, in southern China, can take hours.

The Big Search to Find Out Where Dogs Come From OXFORD, England — Before humans milked cows, herded goats or raised hogs, before they invented agriculture, or written language, before they had permanent homes, and most certainly before they had cats…

The Crispr Quandary One day in March 2011, Emmanuelle Charpentier, a geneticist who was studying flesh-eating bacteria, approached Jennifer Doudna, an award-winning scientist, at a microbiology conference in Puerto Rico.

DISRUPTION, REVOLUTION
A Powerful New Way to Edit DNA In the late 1980s, scientists at Osaka University in Japan noticed unusual repeated DNA sequences next to a gene they were studying in a common bacterium. They mentioned them in the final paragraph of a paper: "The bio…

TOOLS/TECHNIQUES

Lab staple agar hit by seaweed shortage Microbiology's most important reagent is in short supply, with potential consequences for research, public health and clinical labs around the world.


HEALTH/MEDECINE
The tantalizing links between gut microbes and the brain Nearly a year has passed since Rebecca Knickmeyer first met the participants in her latest study on brain development.


UK scientists ready to genetically modify human embryos Scientists in Britain are ready to genetically modify human embryos for the first time as part of a research effort to shed light on the root causes of recurrent miscarriages.

COMPANIES
The $1K Genome? So What? Illumina Is On a Quest for World Domination People can argue all day about whether Illumina has, at last, given us the $1,000 genome. The answer does matter, because the cheaper it gets to sequence a whole human genome, the …
    • The big story is that San Diego-based Illumina (NASDAQ: ILMN) has cemented its position as the dominant player in genomics, at what you could call the beginning of the age of genomic medicine. Through a series of in-house technology advances and savvy business strategy, the company has put itself in an enviable spot. It has a broad and loyal customer base, faces marginal competitive threats, and its market is growing beyond research into the broader world of medical diagnostics


JPM: Illumina's genomic ambitions fueled by new sequencing tools and technology Illumina ($ILMN) has been on a roll this week after launching its new liquid biopsy startup, and the pace isn't showing any signs of slowing. The company revealed additi…

Illumina Jumps into Cancer Screening with $100 Million Spin-off Grail The world’s largest DNA sequencing company says it will form a new company to develop blood tests that cost $1,000 or less and can detect many types of cancer before symptoms aris…

Illumina Announces MiniSeq, a new benchtop sequencer Illumina announced MiniSeq, a new benchtop sequencing system, at this year’s JPM. With MiniSeq, Illumina hopes to offer NGS workflow solution for every lab. MiniSeq is priced at $49,500 USD, to ma…
SOMETHING DIFFERENT

The rise and fall of BlackBerry Though BlackBerry has less than 1% of the smartphone market share today, it once had more than 50%. The question is how such a successful company could fall so far.

The Happiness Code Last summer, three dozen people, mostly programmers in their 20s, gathered in a rented house in San Leandro, Calif., a sleepy suburb of San Francisco, for a lesson in ‘‘comfort-zone expansion.

To Save Its Salmon, California Calls In the Fish Matchmaker HORNBROOK, Calif. — On a frigid morning in a small metal-sided building, a team of specialists prepared to orchestrate an elaborate breeding routine. The work would be wet and messy, so the…






No comments:

Post a Comment